Literature DB >> 895681

An inhibitor to rubella hemagglutination present in bovine albumin preparations: its removal by treatment with kaolin.

J B Campbell, M L Ellins, C Tasios.   

Abstract

Certain commercial preparations of bovine albumin, fraction V, show inhibitory activity in the rubella hemagglutination (HA) and hemagglutination-inhibition (HI) tests. This does not appear to be due to albumin per se, but instead to a contaminant (or contaminants) with the properties of a lipoprotein. All inhibitory activity can be removed from albumin preparations by treatment with kaolin, gel filtration, or flotation ultracentrifugation. We have found that, even when there was no inhibition of HA titers, kaolin treatment of the albumins prior to their incorporation into the test diluent resulted in more clearly defined agglutination patterns. Reasons for and against including albumin in the test diluent are discussed. It is concluded that, although not essential, it is a worthwhile additive. Our data suggest, however, that each batch of albumin used for this purpose should be checked for the presence of inhibitor, and that treatment with kaolin might be considered as a routine step prior to its incorporation into the test diluent.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 895681     DOI: 10.1007/bf02121823

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  19 in total

1.  Influence of albumin on rubella virus hemagglutination and the hemagglutination-inhibition test.

Authors:  J B Campbell; T Grunberger; M L Ellins
Journal:  Can J Microbiol       Date:  1975-08       Impact factor: 2.419

2.  Human serum lipoproteins as inhibitors of haemagglutination for selected togaviruses.

Authors:  K F Shortridge; W K Ho
Journal:  J Gen Virol       Date:  1974-04       Impact factor: 3.891

Review 3.  Practical methods for plasma lipoprotein analysis.

Authors:  F T Hatch
Journal:  Adv Lipid Res       Date:  1968

4.  Identification of non-specific serum inhibitors of rubella virus haemagglutination.

Authors:  H Blom; G Haukenes
Journal:  Med Microbiol Immunol       Date:  1974-06-19       Impact factor: 3.402

5.  The nonspecific inhibitors of rubella-virus hemagglutination.

Authors:  H J Dold; R L Northrop
Journal:  Proc Soc Exp Biol Med       Date:  1968-06

6.  Laboratory diagnosis of rubella virus infections and antibody determinations in routine medical practice.

Authors:  D A Pearson; E C Herrmann
Journal:  Mayo Clin Proc       Date:  1971-07       Impact factor: 7.616

7.  An inhibitor to erythrocyte agglutination in bovine albumin preparations.

Authors:  H H Gunson; P K Phillips
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

8.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

9.  Loss of rubella antibody from immune globulin treated with kaolin.

Authors:  V J Cabasso; R E Louie; K A Hok; C T Robinson; P C Davis; R C Miner
Journal:  Appl Microbiol       Date:  1969-09

10.  Variables of the rubella hemagglutination-inhibition test system and their effect on antigen and antibody titers.

Authors:  N J Schmidt; E H Lennette
Journal:  Appl Microbiol       Date:  1970-03
View more
  1 in total

1.  Use of sodium polyanetholesulfonate-CaCl2 for removal of serum nonspecific inhibitors of rubella hemagglutination: comparison with other polyanion-divalent cation combinations.

Authors:  M L Ellins; J B Campbell
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.